Finorion Pharma India Private Limited, a active private limited company, was established on 23 December 2011 in Mumbai, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the support service to organizations sector, it holds CIN: U74120MH2011PTC225361. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.50 M.
It upholds a compliant status. Employing 149 professional, Its leadership includes Samrudhi Mangesh Utturkar (Director), Rene Kristian Lindell (Director), Mikko Tapani Kemppainen (Additional Director). Past directors included Olli Heikki Huotari, Kalyani Avinash Hendre, Jari Ilmari Karlson. Its latest AGM occurred on 22 September 2025, with the balance sheet filed on 31 March 2025. It is based at Smartworks Coworking Location, Times Square Building, 9Th Floor, C Wing, Andheri Marol, Andheri East, Mumbai, Mumbai, Maharashtra, 400059.
U74120MH2011PTC225361
225361
23 December 2011
₹0.50 M
₹0.50 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Finorion Pharma India Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Samrudhi Mangesh Utturkar | Director | 29 May 2018 | Current |
| Rene Kristian Lindell | Director | 05 Aug 2024 | Current |
| Mikko Tapani Kemppainen | Additional Director | 24 Apr 2025 | Current |
| Pekka Juhani Kankaanpaa | Additional Director | 24 Apr 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 31 Mar 2025 | Past |
| Pramod Abcsdd | Director | 29 May 2018 | Past |
| Pramod Abcsdd | Director | 05 Mar 2024 | Past |
| Pramod Abcsdd | Additional Director | 25 Sep 2018 | Past |
| Pramod Abcsdd | Additional Director | 19 Sep 2024 | Past |
| Pramod Abcsdd | Additional Director | 21 Sep 2016 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Finorion Pharma India Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 6.58% increase. The company also saw a substantial improvement in profitability, with a 17.34% increase in profit. The company's net worth Soared by an impressive increase of 16.08%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Finorion Pharma India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Finorion Pharma India has a workforce of 149 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Finorion Pharma India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Finorion Pharma India's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Finorion Pharma India Private Limited last Annual general meeting of members was held on 22 Sep 2025 as per latest MCA records. was recorded as a recent event.
Progress on Mikko Tapani Kemppainen was appointed as a Additional Director was appointed as a Additional Director on 24 Apr 2025 & has been associated with this company since 7 months 25 days . was documented.
Progress on Pekka Juhani Kankaanpaa was appointed as a Additional Director was appointed as a Additional Director on 24 Apr 2025 & has been associated with this company since 7 months 25 days . was documented.
Finorion Pharma India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was recorded as a recent event.
The activity Rene Kristian Lindell was appointed as a Director was appointed as a Director on 05 Aug 2024 & has been associated with this company since 1 year 4 months . was completed.
Samrudhi Mangesh Utturkar was appointed as a Director was appointed as a Director on 29 May 2018 & has been associated with this company since 7 years 6 months . was recorded as a recent event.
Me trying to break into the biopharmaceuticals industry like: "Hey guys, can I join the cool kids club too? I promise I have snacks and candy!" #SnacksForScience #BiopharmaNewbie.
The CIN of Finorion Pharma India Private Limited is U74120MH2011PTC225361.
Finorion Pharma India Private Limited is headquartered at Smartworks Coworking Location, Times Square Building, 9Th Floor, C Wing, Andheri Marol, Andheri East, Mumbai, Mumbai, Maharashtra, 400059.
Finorion Pharma India Private Limited was incorporated on 23 December 2011.
The current directors of Finorion Pharma India Private Limited are
The primary industry of Finorion Pharma India Private Limited is Support Service To Organizations.
Finorion Pharma India Private Limited is unlisted.
The authorized capital of Finorion Pharma India Private Limited is ₹0.50 M, and the paid-up capital is ₹0.50 M.
The compliance status of Finorion Pharma India Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX